ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society

Cited by (1,004)

Items 601–700 of 1,004

1. Heart Failure with Preserved Ejection Fraction: Hypertension, Diabetes, Obesity/Sleep Apnea, and Hypertrophic and Infiltrative Cardiomyopathy
   Akshay Suvas Desai, James Chen-Tson Fang · 2008 · Heart Failure Clinics
2. Breaking bad news sensitively: what is important to patients in their last year of life?
   Barbara Hanratty, Elizabeth Lowson, Louise Holmes, Gunn Grande, Ann Jacoby, Sheila Alison Payne, Jane Elizabeth Seymour, Margaret Whitehead · 2011 · BMJ Supportive & Palliative Care
3. Improving Quality of Care and Outcomes for Heart Failure - Role of Registries -
   Gregg C. Fonarow · 2011 · Circulation Journal
4. Disability in patients with end‐stage liver disease: Results from the functional assessment in liver transplantation study
   Mariya L. Samoylova, Kenneth E. Covinsky, Marta Haftek, Selena Z. Kuo, John P. Roberts, Jennifer C. Lai · 2016 · Liver Transplantation
5. Comparative Effects of Carvedilol vs Bisoprolol for Severe Congestive Heart Failure - Special Reference to Atrial Fibrillation -
   Masanori Konishi, Go Haraguchi, Shigeki Kimura, Hiroshi Inagaki, Mihoko Kawabata, Hitoshi Hachiya, Kenzo Hirao, Mitsuaki Isobe · 2010 · Circulation Journal
6. Impact of Baseline Systolic Blood Pressure on Long-Term Outcomes in Patients With Advanced Chronic Systolic Heart Failure (Insights from the BEST Trial)
   Ravi V. Desai, Maciej Banach, Mustafa I. Ahmed, Marjan U. Mujib, Inmaculada Aban, Thomas E. Love, Michel White, Gregg C. Fonarow, PRAKASH C. DEEDWANIA, Wilbert S. Aronow et al. · 2010 · The American Journal of Cardiology
7. Baseline differences in the HF-ACTION trial by sex
   Ileana L. Piña, Peter F Kokkinos, Andrew C. Kao, Vera Bittner, Matt Saval, Bob Clare, Lee R. Goldberg, Maryl R. Johnson, Ann Marie Swank, Héctor O. Ventura et al. · 2009 · American Heart Journal
8. Reversing Advanced Heart Failure by Targeting Ca2+Cycling
   David M. Kaye, Masahiko Hoshijima, Kenneth R. Chien · 2008 · Annual Review of Medicine
9. Circulating Neuregulin During the Transition From Stage A to Stage B/C Heart Failure in a Breast Cancer Cohort
   Carrie Anna Geisberg, Wissam M. Abdallah, Monica da Silva, Cheri A. Silverstein, Holly Smith, Vandana Gupta Abramson, Ingrid A. Mayer, Julie Ann Means-Powell, Darla Freehardt, Brenda W. White et al. · 2012 · Journal of Cardiac Failure
10. Gender Differences in Guideline-Directed Medical Therapy for Cardiovascular Disease Among Young Veterans
    Sanket Shishir Dhruva, James D Dziura, Harini Bathulapalli, Lindsey Rosman, Allison E. Gaffey, Melinda Baughman Davis, Cynthia Brandt, Sally G. Haskell · 2022 · Journal of General Internal Medicine
11. Nurses' Knowledge of Heart Failure Self‐Management
    Elizabeth W. Willette, Danielle Surrells, Leslie L. Davis, Charles T. Bush · 2007 · Progress in Cardiovascular Nursing
12. Fatigue With Systolic Heart Failure
    Anne M. Fink, Shawna L. Sullivan, Julie Johnson Zerwic, Mariann R. Piano · 2009 · The Journal of Cardiovascular Nursing
13. Psychometric properties of the Kansas City Cardiomyopathy Questionnaire (KCCQ)
    Ruth Masterson Creber, Rosemary C. Polomano, John T. Farrar, Barbara J. Riegel · 2012 · European Journal of Cardiovascular Nursing
14. Prognostic Role of Hypothyroidism in Heart Failure
    Ning Ning, Dengfeng Gao, Vincenzo Triggiani, Massimo Iacoviello, Judith E. Mitchell, Rui Ma, Yan Zhang, Huijuan Kou · 2015 · Medicine
15. Heart Failure in Older Adults
    Michael W. Rich · 2006 · Medical Clinics of North America
16. Towards a Personal Health Management Assistant
    Ferguson, G., Quinn, J., Horwitz, C., Swift, M., Allen, J., Galescu, L. · 2010 · Journal of Biomedical Informatics
17. Cost-Effectiveness of Ventricular Assist Device Therapy as a Bridge to Transplantation Compared With Nonbridged Cardiac Recipients
    Ana Carolina Alba, L.F. Alba, Diego Delgado, Vivek Rao, Heather Joan Ross, Ron A. Goeree · 2013 · Circulation
18. High-Sensitivity Troponin T and Cardiovascular Events in Systolic Blood Pressure Categories
    Yashashwi Pokharel, Wensheng Sun, James A. de Lemos, George E. Taffet, Salim S. Virani, Chiadi E. Ndumele, Thomas H. Mosley, Ron Cornelis Hoogeveen, Josef Coresh, Jacqueline D. Wright et al. · 2014 · Hypertension
19. Epigenetics in the heart: the role of histone modifications in cardiac remodelling
    Asmita Tingare, Bernard Thienpont, H. Llewelyn Roderick · 2013 · Biochemical Society Transactions
20. Converging Indications of Aldosterone Antagonists (Spironolactone and Eplerenone): A Narrative Review of Safety Profiles
    Mohammed Ibn-Mas’ud Danjuma, Ipshita Mukherjee, Janine Makaronidis, Serge Osula · 2014 · Current Hypertension Reports
21. Prevalence and Impact of Central Sleep Apnea in Heart Failure
    Patrick A. Levy, Jean‐Louis Pépin, Renaud Tamisier, Yannick Neuder, Jean-Philippe Baguet, Shahrokh Javaheri · 2007 · Sleep Medicine Clinics
22. Clinical Effectiveness of Cardiac Resynchronization and Implantable Cardioverter-Defibrillator Therapy in Men and Women With Heart Failure
    Jane E. Wilcox, Gregg C. Fonarow, Yan Zhang, Nancy M. Albert, Anne B. Curtis, Mihai Gheorghiade, James Thomas Heywood, Mandeep R. Mehra, Christopher M. O’Connor, DWIGHT W. REYNOLDS et al. · 2013 · Circulation Heart Failure
23. Sex and Intimacy Among Patients With Implantable Left-Ventricular Assist Devices
    Linda Marcuccilli, Jesus M. Casida, Rosalind M. Peters, Susan M. Wright · 2011 · The Journal of Cardiovascular Nursing
24. Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death
    Ludger Hauck, Shanna Stanley-Hasnain, Amelia Fung, Daniela Grothe, Vivek Rao, Tak W. Mak, Filio Billia · 2017 · PLoS ONE
25. Adropin and Irisin in Patients with Cardiac Cachexia
    Ali Kemal Kalkan, Hüseyin Altuğ Çakmak, Mehmet Ertürk, Kübra Kalkan, Fatih Uzun, Ömer Taşbulak, Vesile Örnek Diker, Süleyman Aydın, Ahmet Çelik · 2018 · Arquivos Brasileiros de Cardiologia
26. The current role of cardiac resynchronization therapy in reducing mortality and hospitalization in heart failure patients: a meta-analysis from clinical trials
    Andrea Rossi, Giuseppe Rossi, Marcello Piacenti, Umberto Startari, Luca Panchetti, Maria‐Aurora Morales · 2008 · Heart and Vessels
27. Value of Medical Therapy in Patients >80 Years of Age With Heart Failure and Preserved Ejection Fraction
    Faramarz Tehrani, Anita Phan, Christopher Chien, Ryan P. Morrissey, Asim M. Rafique, Ernst R. Schwarz · 2009 · The American Journal of Cardiology
28. Donors After Circulatory Death Heart Trial
    Yasuhiro Shudo, Rhodalene Benjamin-Addy, Tiffany K. Koyano, William Hiesinger, John Ward MacArthur, Yi-Ping Joseph Woo · 2020 · Future Cardiology
29. A mouse model of reverse cardiac remodelling following banding‐debanding of the ascending aorta
    Johannes Lagethon Bjørnstad, Biljana Skrbic, I. Sjaastad, Sigrid Bjørnstad, Geir Christensen, Theis Tønnessen · 2011 · Acta Physiologica
30. Left ventricular dysfunction in the haemodialysis population
    Manish M. Sood, Robert P. Pauly, Claudio Rigatto, Paul V. J. Komenda · 2008 · Clinical Kidney Journal
31. Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy
    D. R. Tomlinson, Yasmeen Bashir, Timothy R. Betts, Kim Rajappan · 2009 · EP Europace
32. Management of Heart Failure Patients with Reduced Ejection Fraction
    Douglas L. Mann · 2012 · Elsevier eBooks
33. Impact of Telemonitoring on Health Status
    Natalie Margaret Jayaram, Yevgeniy Khariton, Harlan M. Krumholz, Sarwat I. Chaudhry, Jennifer A. Mattera, Fengming Tang, Jeph S. Herrin, Beth Hodshon, John A. Spertus · 2017 · Circulation Cardiovascular Quality and Outcomes
34. Echocardiography and Risk Prediction in Advanced Heart Failure: Incremental Value Over Clinical Markers
    Syed Abbas Agha, Andreas P. Kalogeropoulos, Jeffrey A. Shih, Vasiliki V. Georgiopoulou, Grigorios Giamouzis, Perry Anarado, Deepa Mangalat Gopal, Imad Hussain, Wendy Book, Sonjoy R. Laskar et al. · 2009 · Journal of Cardiac Failure
35. Comparison of myocardial performance index obtained either by conventional echocardiography or tissue Doppler echocardiography in healthy subjects and patients with heart failure
    Mehmet Akif Düzenli, Kurtuluş Özdemir, Nazif Aygül, Ahmet Soylu, Meryem Ülkü Aygül, Hasan Gök · 2009 · Heart and Vessels
36. Growth differentiation factor 15 in different stages of heart failure: potential screening implications
    Fangfang Wang, Yanhong Guo, Haiyi Yu, Ling-bing Zheng, Lin Mi, Wei Dong Gao · 2010 · Biomarkers
37. Similarities and Differences between the Pathogenesis and Pathophysiology of Diastolic and Systolic Heart Failure
    Kazuo Komamura · 2013 · Cardiology Research and Practice
38. Unmet Needs Following Hospitalization With Heart Failure
    Patricia Mary Davidson, Jill Cockburn, Phillip J. Newton · 2008 · The Journal of Cardiovascular Nursing
39. Health‐related quality of life of patients with severe heart failure. A cross‐sectional multicentre study
    Nikolaos V. Fotos, Konstantinos Giakoumidakis, Zoi Kollia, Petros Galanis, Panagiota Copanitsanou, Evangelia Pananoudaki, Hero Brokalaki · 2012 · Scandinavian Journal of Caring Sciences
40. Anti-Remodeling Effects of Rapamycin in Experimental Heart Failure: Dose Response and Interaction with Angiotensin Receptor Blockade
    Kalkidan G. Bishu, Ozgur Ogut, Sudhir S. Kushwaha, Selma F. Mohammed, Tomohito Ohtani, Xiaolei Xu, Frank V. Brozovich, Margaret M. Redfield · 2013 · PLoS ONE
41. Psychometric Testing of the MDASI-HF: A Symptom Assessment Instrument for Patients With Cancer and Concurrent Heart Failure
    Anecita P. Fadol, Tito R. Mendoza, Ibrahima Gning, Jeanette G. Kernicki, Lene Symes, Charles S. Cleeland, Daniel John Lenihan · 2008 · Journal of Cardiac Failure
42. Comparison of Predictors of Heart Failure–Related Hospitalization or Death in Patients With Versus Without Preserved Left Ventricular Ejection Fraction
    Ashvarya Mangla, John Kane, Elijah Beaty, DeJuran Richardson, Lynda H. Powell, James E. Calvin · 2013 · The American Journal of Cardiology
43. Investigating Pain in Heart Failure Patients: Rationale and Design of the Pain Assessment, Incidence & Nature in Heart Failure (PAIN-HF) Study
    Sarah J. Goodlin, Sue Wingate, Susan J. Pressler, John R. Teerlink, C. Porter Storey · 2008 · Journal of Cardiac Failure
44. The Paracrine Effect: Pivotal Mechanism in Cell-Based Cardiac Repair
    Simon Maltais, Jacques P. Tremblay, Louis P. Perrault, Hung Q. Ly · 2010 · Journal of Cardiovascular Translational Research
45. Outpatient Palliative Cardiology Service Embedded Within a Heart Failure Clinic: Experiences With an Emerging Model of Care
    Benjamin T. Gandesbery, Krista R. Dobbie, Eiran Z. Gorodeski · 2017 · American Journal of Hospice and Palliative Medicine®
46. Obesity paradox and heart failure
    Maria Pia Donataccio, Angiola Vanzo, Ottavio Bosello · 2020 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
47. Circulating exosomal microRNAs as emerging non‐invasive clinical biomarkers in heart failure: Mega bio‐roles of a nano bio‐particle
    Runfa Zhou, Leiyan Wang, Gang Zhao, Dan Chen, Xiaoning Song, Amir Abbas Momtazi‐Borojeni, Haitao Yuan · 2020 · IUBMB Life
48. Determinants of Steady-State Torasemide Pharmacokinetics
    Dierk Werner, Ulrike Werner, Annett Meybaum, Boris Schmidt, Sumaira Umbreen, Anton Grosch, H Lestin, Bernhard Graf, Oliver Zolk, Martin F. Fromm · 2008 · Clinical Pharmacokinetics
49. Optimal Antagonism of the Renin-Angiotensin-Aldosterone System
    Christian M. Werner, Janine Pöss, Michael Böhm · 2010 · Drugs
50. Cardiac Resynchronization Therapy and Atrial Overdrive Pacing for the Treatment of Central Sleep Apnoea
    Lars Lüthje, Bernd Renner, Roger Kessels, Dirk Vollmann, Tobias Raupach, Bart Gerritse, Selçuk Tasci, JÖRG OTTO SCHWAB, Markus Zabel, Dieter Zenker et al. · 2009 · European Journal of Heart Failure
51. Comparative Effectiveness of Beta-Adrenergic Antagonists (Atenolol, Metoprolol Tartrate, Carvedilol) on the Risk of Rehospitalization in Adults With Heart Failure
    Alan S. Go, Jingrong Yang, Jerry H. Gurwitz, John Hsu, Kimberly Lane, Richard G. Platt · 2007 · The American Journal of Cardiology
52. Effect of the Wenchuan Earthquake in China on Hemodynamically Unstable Ventricular Tachyarrhythmia in Hospitalized Patients
    Xiao Qiang Zhang, Mao Chen, Qing Yang, Shao Di Yan, De Jia Huang · 2009 · The American Journal of Cardiology
53. Race, Sex, and Age Differences in Heart Failure-Related Hospitalizations in a Southern State
    Baqar A. Husaini, George A. Mensah, Douglas B. Sawyer, Van A. Cain, Zahid Samad, Pamela C. Hull, Robert S. Levine, Uchechukwu K.A. Sampson · 2010 · Circulation Heart Failure
54. Circulating Long Non-coding RNA ENST00000507296 Is a Prognostic Indicator in Patients with Dilated Cardiomyopathy
    Xudong Zhang, Xiang Nie, Shuai Yuan, Huaping Li, Jiahui Fan, Chenze Li, Yang Sun, Yanru Zhao, Huiying Hou, Dao Wen Wang et al. · 2019 · Molecular Therapy — Nucleic Acids
55. Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance
    Aldo Clerico, Martina Zaninotto, Alberto Aimo, Daniela Maria Cardinale, Ruggero Dittadi, Maria Teresa Sandri, Marco Alfonso Perrone, Lucia Belloni, Antonio Fortunato, Tommaso Trenti et al. · 2023 · Clinical Chemistry and Laboratory Medicine (CCLM)
56. Chronic Disease Management for Patients With Cirrhosis
    Michael L. Volk, John D. Piette, Amit S. Singal, Anna Suk-Fong Lok · 2010 · Gastroenterology
57. High sensitive troponin T and heart fatty acid binding protein: Novel biomarker in heart failure with normal ejection fraction?: A cross-sectional study
    Wilfried Dinh, Werner Nickl, Reiner Füth, Mark Lankisch, Georg Heß, Dietmar Zdunek, Thomas Scheffold, Michael Coll Barroso, Klaus A. Tiroch, Dan Ziegler et al. · 2011 · BMC Cardiovascular Disorders
58. Morbidity and prognostic factors in chronic chagasic cardiopathy
    Manoel Otávio da Costa Rocha, Maria Carmo Pereira Nunes, Antônio Luiz Pinho Ribeiro · 2009 · Memórias do Instituto Oswaldo Cruz
59. Central mechanisms for exercise training-induced reduction in sympatho-excitation in chronic heart failure
    Haack, Karla K.V., Zucker, Irving H. · 2015 · Autonomic Neuroscience
60. The Bridge Project: Improving Heart Failure Care in Skilled Nursing Facilities
    Rebecca S. Boxer, Mary A. Dolansky, Megan A. Frantz, Regina Prosser, Jeanne A. Hitch, Ileana L. Piña · 2011 · Journal of the American Medical Directors Association
61. The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?
    Yeshun Wu, Bin Zhu, Ailin Luo, Ling Yang, Chun Yang · 2018 · BioMed Research International
62. Amino Acid-Based Metabolic Panel Provides Robust Prognostic Value Additive to B-Natriuretic Peptide and Traditional Risk Factors in Heart Failure
    Chao‐Hung Wang, Mei‐Ling Cheng, Min‐Hui Liu · 2018 · Disease Markers
63. Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography
    Timothy C. Tan, Marielle Scherrer‐Crosbie · 2012 · Current Cardiovascular Imaging Reports
64. Biomarkers in Trypanosoma cruzi-Infected and Uninfected Individuals with Varying Severity of Cardiomyopathy in Santa Cruz, Bolivia
    Emi E. Okamoto, Jacqueline E. Sherbuk, Eva H. Clark, Morgan A. Marks, Omar Gandarilla, Gerson Galdos‐Cardenas, Angel Vasquez-Villar, Jeong Choi, Thomas Crawford, Rose Q. Do et al. · 2014 · PLoS neglected tropical diseases
65. Application of multilayer perceptron and radial basis function neural networks in differentiating between chronic obstructive pulmonary and congestive heart failure diseases
    Saeed Mehrabi, Mehran Maghsoudloo, Hossein Arabalibeik, Rezvan Noormand, Yones Nozari · 2008 · Expert Systems with Applications
66. Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
    Stuart Mealing, Beth S. Woods, Neil Hawkins, Martín Cowie, Chris Plummer, William T. Abraham, John F. Beshai, Helmut Klein, Mark John Sculpher · 2016 · Heart
67. Hymenoptera venom immunotherapy while maintaining cardiovascular medication: safe and effective
    Johanna Stoevesandt, Christine Hosp, Andreas Kerstan, Axel Trautmann · 2015 · Annals of Allergy Asthma & Immunology
68. From Insiders' Perspectives: Adjusting to Caregiving for Patients with Left Ventricular Assist Devices
    Linda Marcuccilli, Jesus M. Casida · 2011 · Progress in Transplantation
69. Racial and ethnic differences in subclinical myocardial function: the Multi-Ethnic Study of Atherosclerosis
    Verônica Fernandes, Susan C. Cheng, Yu-Jen Cheng, Boaz D. Rosen, Sachin Agarwal, Robyn L. McClelland, David A. Bluemke, João A.C. Lima · 2011 · Heart
70. The use of combination therapy in pulmonary arterial hypertension: new developments
    Nazzareno Galiè, L. Negro, Gérald Simonneau · 2009 · European Respiratory Review
71. Gender Differences in Continuous-Flow Left Ventricular Assist Device Therapy as a Bridge to Transplantation: A Risk-Adjusted Comparison Using a Propensity Score-Matching Analysis
    Alexander Weymann, Nikhil P. Patil, Anton Sabashnikov, Prashant Nanasaheb Mohite, Diana García Sáez, Mohamed Amrani, Toufan T. Bahrami, Fabio De Robertis, Thorsten Wahlers, Nicholas Robert Banner et al. · 2014 · Artificial Organs
72. Clinical Effectiveness of Hydralazine–Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry
    Prateeti Khazanie, Li Liang, Lesley H. Curtis, Javed Butler, Zubin J. Eapen, Paul A. Heidenreich, Deepak L. Bhatt, Eric David Peterson, Clyde W. Yancy, Gregg C. Fonarow et al. · 2016 · Circulation Heart Failure
73. Rationale and design of the Children’s Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at high risk for developing heart failure
    Saro H. Armenian, Melissa Maria Hudson, Ming Hui Chen, Steven D. Colan, Lanie Lindenfeld, George Mills, Aida Siyahian, Sarah K. Gelehrter, Ha M. Dang, Wendy Hein et al. · 2016 · BMC Cardiovascular Disorders
74. Standardizing care for acute decompensated heart failure in a large megatrial: The approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF)
    Justin Adrian Ezekowitz, Adrian F. Hernandez, Randall C. Starling, Clyde W. Yancy, Barry M. Massie, James A. Hill, Henry Krum, Rafael Díaz, Piotr P. Ponikowski, Marco Metra et al. · 2008 · American Heart Journal
75. Heart Failure Worsening and Exacerbation After Venlafaxine and Duloxetine Therapy
    Vincent J Colucci, Bradley D. Berry · 2008 · Annals of Pharmacotherapy
76. Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure
    Mihai Gheorghiade, James D. Flaherty, Gregg C. Fonarow, Ravi V. Desai, Richard Lee, David C. McGiffin, Thomas E. Love, Inmaculada Aban, Eric J. Eichhorn, Robert O. Bonow et al. · 2010 · International Journal of Cardiology
77. Atrial fibrillation and long-term prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS)
    Avraham Shotan, Moshe Garty, D. S. Blondhein, Simcha Ron Meisel, B. S. Lewis, Michael Kleiner Shochat, Ehud Grossman, A. Porath, V. Boyko, Reuven Zimlichman et al. · 2009 · European Heart Journal
78. Insuficiencia cardíaca crónica en el paciente anciano
    David Chivite, Jhonatan Franco, Francesç Formiga · 2015 · Revista Española de Geriatría y Gerontología
79. The effects of β-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis
    Pascal de Groote, Pierre Delour, Frédéric Mouquet, Nicolas Lamblin, Joël Dagorn, Olivier Hennebert, Thierry Le Tourneau, Claude Hossein-Foucher, Christine Verkindère, Christophe Bauters · 2007 · American Heart Journal
80. Cardiac Autonomic Nerve Stimulation in the Treatment of Heart Failure
    Mariko Kobayashi, ALEX L. MASSIELLO, Jamshid H. Karimov, David R. Van Wagoner, Kiyotaka Fukamachi · 2013 · The Annals of Thoracic Surgery
81. SmartDelay Determined AV Optimization: A Comparison of AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV): Rationale and Design
    Kenneth M. Steín, Kenneth A. Ellenbogen, Michael Robert Gold, Bernd Lemke, Ignacio Fernández Lozano, Suneet Mittal, Francis G. Spinale, Jennifer E. Van Eyk, Alan D. Waggoner, Timothy E. Meyer · 2009 · Pacing and Clinical Electrophysiology
82. An alternative approach to understanding the pathophysiological mechanisms of chronic heart failure
    David Hunter MacIver, Mark Dayer · 2011 · International Journal of Cardiology
83. Coronary Artery Bypass Grafting With or Without Surgical Ventricular Restoration: A Comparison
    Roni B. Prucz, Eric S. Weiss, Nishant Patel, Lois U. Nwakanma, William A. Baumgartner, John V. Conte · 2008 · The Annals of Thoracic Surgery
84. Progression of Preclinical Heart Failure: A Description of Stage A and B Heart Failure in a Community Population
    Kathleen A. Young, Christopher G. Scott, Richard J. Rodeheffer, Horng H. Chen · 2021 · Circulation Cardiovascular Quality and Outcomes
85. Cardiotoxicity Due to Chemotherapy: Role of Cardiac Imaging
    Frédéric Poulin, Paaladinesh Thavendiranathan · 2015 · Current Cardiology Reports
86. Dietary Sodium Adherence Is Poor in Chronic Heart Failure Patients
    Anupam Basuray, Mary A. Dolansky, Richard Josephson, Abdus Sattar, Ellen M. Grady, Anton Vehovec, John Gunstad, Joseph D. Redle, James Chen-Tson Fang, Joel W. Hughes · 2015 · Journal of Cardiac Failure
87. The Epidemiology of Heart Failure in Adults with Congenital Heart Disease
    Fred H. Rodriguez, Ariane J. Marelli · 2013 · Heart Failure Clinics
88. Quality of Care Associated with Common Chronic Diseases in a 9-State Medicaid Population Utilizing Claims Data: An Evaluation of Medication and Health Care Use and Costs
    Julie L. Priest, Christopher Ron Cantrell, Jack E. Fincham, Christopher L. Cook, Steven P. Burch · 2010 · Population Health Management
89. Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?
    Jennifer Franke, Jan Sebastian Wolter, Lillian Meme, Jeannette Keppler, Ramon Tschierschke, Hugo Albert Katus, Christian Zugck · 2012 · Clinical Research in Cardiology
90. Long-term trends in use of and expenditures for cardiovascular medications in Canada
    Cynthia Anne Jackevicius, Jafna L. Cox, D. Carreon, Jack V. Tu, Stéphane Rinfret, Derek Y F So, Helen Johansen, Dimitri Kalavrouziotis, Virginie Demers, Karin H. Humphries et al. · 2009 · Canadian Medical Association Journal
91. Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials
    Wei Xin, Wei Wei, Xiaoying Li · 2012 · Heart
92. Chronic Pain in Chronic Heart Failure: A Review Article.
    Mohammad Javad Alemzadeh‐Ansari, Mohammad Mostafa Ansari Ramandi, Nasim Naderi · 2017 · Europe PMC (PubMed Central)
93. Heart Failure With Mid-range Ejection Fraction
    Pratyaksh K. Srivastava, Jeffrey J. Hsu, Boback Ziaeian, Gregg C. Fonarow · 2020 · Current Heart Failure Reports
94. Cardioprotection with beta‐blockers: myths, facts and Pascal’s wager
    Franz H. Messerli, Sripal Bangalore, Siu‐Sun Yao, Jonathan S. Steinberg · 2009 · Journal of Internal Medicine
95. The Use of Advance Directives Among Patients with Left Ventricular Assist Devices
    Keith Mark Swetz, Paul S. Mueller, Abigale L. Ottenberg, Chadi Dib, Monica R. Freeman, Daniel P. Sulmasy · 2011 · Hospital Practice
96. Digoxin: Current Use and Approach to Toxicity
    Selim R. Krim, Rey Percival Vivo, Joanne Perez, Mahakit Inklab, Thomas E. Tenner, John Hodgson · 2008 · The American Journal of the Medical Sciences
97. Management of Hypertension among Patients with Coronary Heart Disease
    Oladipupo Olafiranye, Ferdinand Zizi, Perry Brimah, Girardin Jean‐Louis, Amgad N. Makaryus, Samy I. McFarlane, Gbenga G Ogedegbe · 2011 · International Journal of Hypertension
98. Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age
    Jochem van den Berg, Jan L.M. Strengers, Piotr A. Wielopolski, Wim C.J. Hop, Folkert Jan Meijboom, Yolanda B. de Rijke, Frans Boomsma, Ad J.J.C. Bogers, Peter M. T. Pattynama, Willem A. Helbing · 2008 · International Journal of Cardiology
99. Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure
    Mara Slawsky, Michael M. Givertz · 2009 · Expert Opinion on Pharmacotherapy
100. Randomized, Double-Blinded, Multicenter, Placebo-Controlled Trial of Shenfu Injection for Treatment of Patients with Chronic Heart Failure during the Acute Phase of Symptom Aggravation (Yang and Qi Deficiency Syndrome)
     Xianliang Wang, Zhiqiang Zhao, Jingyuan Mao, Tinghai Du, Yuanping Chen, Hao Xu, Nan Liu, Xiaolong Wang, Jianguang Wu, Rong Li et al. · 2019 · Evidence-based Complementary and Alternative Medicine